// App-Quantinova.ai

3230 : The role of TRF2 on tumor progression in non-small cell lung cancer: potential modulating effect on myeloid cells

Researchers

Presenter

  • Linda Bouhlel

Principal Investigators

  • Marius Ilie

  • Laurie Signetti

  • Julien Cherfils-Vicini

  • Eric Selva

  • Patrick Brest

  • Charles Hugo Marquette

  • Eric Gilson

  • Paul Hofman

Medical Centers

  • CHU Nice, Pneumology Department and IRCAN CNRS UMR /INSERM U , University of Nice Sophia Antipolis, Nice, France

  • CHU Nice, Laboratory of Clinical and Experimental Pathology and Institut for Research on Cancer and Aging Nice (IRCAN) CNRS UMR /INSERM U Faculty of Medicine Nice University, Nice, France

  • CHU Nice, Pneumology Department and Institut for Research on Cancer and Aging Nice (IRCAN) CNRS UMR /INSERM U Faculty of Medicine Nice University, Nice, France.

  • CHU Nice, Hospital-Integrated Biobank BB- - , Nice, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Circulating tumor cells

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved